Table 1 Baseline clinical characteristics
Variables | DM N = 81 | Non-DM N = 173 | P-value |
|---|---|---|---|
Basic variables | |||
Age (years) | 60.22 ± 10.36 | 59.42 ± 10.68 | 0.572 |
Male (%) | 65 (80.2%) | 136 (78.6%) | 0.869 |
Smoking (%) | 20 (24.7%) | 44 (25.4%) | 0.950 |
Prior diseases | |||
Hyperlipidemia (%) | 38 (46.9%) | 87 (50.3%) | 0.687 |
Previous MI (%) | 7 (8.6%) | 22 (12.7%) | 0.402 |
Hypertension (%) | 37 (45.7%) | 77 (44.5%) | 0.632 |
Chronic renal insufficiency (%) | 12 (14.8%) | 25 (14.5%) | 0.873 |
Clinical presentation | |||
Stable angina (%) | 52 (64.2%) | 99 (57.2%) | 0.646 |
Unstable angina (%) | 21 (25.9%) | 48 (27.7%) | |
NSTEMI (%) | 5 (6.2%) | 15 (8.7%) | |
STEMI (%) | 3 (3.7%) | 11 (6.4%) | |
Medication | |||
ACEI/ARB (%) | 53 (65.4%) | 119 (68.8%) | 0.666 |
Dural antiplatelet therapy (%) | 73 (90.1%) | 149 (86.1%) | 0.423 |
Statin therapy (%) | 75 (92.6%) | 151 (87.3%) | 0.283 |
Lab parameters | |||
Fasting glucose | 7.647 ± 2.416 | 5.586 ± 1.189 | <0.001 |
Hemoglobin A1c | 7.373 ± 1.216 | 5.463 ± 0.754 | <0.001 |
Type of restenosis | |||
Early restenosis | 27 (24.8%) | 82 (48.2%) | 0.04 |
Non-focal restenosis (%) | 23 (28.4%) | 64 (37%) | 0.203 |